Testing new treatments for viral infections.
Official title: TASK B26: COMPREHENSIVE VIRAL SCREENING PANEL.
Funded at University of Alabama at Birmingham · NIH-11307308 · Data updated 2026-11-12
This study is looking for new treatments to help fight viral infections by testing different anti-viral agents in the lab, and the results could lead to better options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | December 16, 2024 |
| Project end | December 15, 2025 |
| Funding year | 2025 |
| Award (this year) | $347,296 |
| NIH project number | 75N93019D00016-0-759302500001-2 |
| Project ID | NIH-11307308 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from viral infections who may benefit from new anti-viral therapies.
✕Less likely to help
Patients with bacterial infections or non-viral illnesses may not receive any benefit from this research.
What this research studies
This research focuses on evaluating potential anti-viral agents through laboratory testing. It involves maintaining viral stocks and cell lines, which are essential for growing viruses in a controlled environment. The goal is to develop assays that can help identify effective treatments for viral infections. Patients may benefit from advancements in anti-viral therapies that emerge from these findings.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for various viral infections.
How similar studies have gone: Previous research has shown success in developing effective anti-viral treatments through similar laboratory testing approaches.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: James, Scott — University of Alabama at Birmingham
- Study coordinator: James, Scott
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Exploring how Down syndrome affects optic nerve health in kids
A study using a mouse model to understand why optic nerve problems are common in children with Down syndrome and how to prevent them.
-
Global bromocriptine trial for postpartum cardiomyopathy
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with peripartum cardiomyopathy.
-
Global Bromocriptine Add-on for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding the dopamine agonist bromocriptine to standard heart failure care helps postpartum women with a specific heart condition.
-
Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.
-
Bromocriptine as add-on therapy for postpartum cardiomyopathy across multiple sites
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with postpartum cardiomyopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.